Zobrazeno 1 - 3
of 3
pro vyhledávání: '"E K, Frimpong"'
Publikováno v:
Canadian Journal of Microbiology. 45:732-739
In Japan, antimicrobial agent therapy for patients with diarrhea due to enterovirulent organisms including enterohemorrhagic Escherichia coli (EHEC) is common, and norfloxacin (NFLX), fosfomycin, and kanamycin are recommended for EHEC treatment by th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3ccfc9f5714378ad26bf53ab9324670a
https://doi.org/10.1139/w99-069
https://doi.org/10.1139/w99-069
Publikováno v:
FEMS Immunology & Medical Microbiology. 19:57-64
In 1996, Japan had several large outbreaks of enterohaemorrhagic Escherichia coli (EHEC) O157:H7 infection. We surveyed physicians who examined and treated these patients, and found that most of the patients (95.9%) received antimicrobial agents as t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a2eedea293e734f6413aa172de82cf64
https://doi.org/10.1111/j.1574-695x.1997.tb01072.x
https://doi.org/10.1111/j.1574-695x.1997.tb01072.x
Publikováno v:
Canadian journal of microbiology. 45(9)
In Japan, antimicrobial agent therapy for patients with diarrhea due to enterovirulent organisms including enterohemorrhagic Escherichia coli (EHEC) is common, and norfloxacin (NFLX), fosfomycin, and kanamycin are recommended for EHEC treatment by th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::1b1ec23ca641d58eda91671ce030cd2a
https://pubmed.ncbi.nlm.nih.gov/10526400
https://pubmed.ncbi.nlm.nih.gov/10526400